Patents Archives

Best in Biotech 5 Dec 2024

Five biosimilar companies you should know about

Discover five biosimilar companies creating affordable versions of blockbuster drugs and hoping to capitalize on the upcoming patent cliff.

December 5, 2024 - 11 minutesmins - By Willow Shah-Neville

In Depth 11 Dec 2023

European patents in biotech: how to prevent invalid patents?

The ongoing patent battle between COVID-19 vaccine giants, Pfizer-BioNTech and Moderna, has seen a new development when the European Patent Office (EPO) invalidated one of Moderna’s patents related to “respiratory virus vaccines.” BioNTech, in collaboration with Pfizer and Sanofi, opposed the patent, leading to its invalidation. The European patent process is complex but essential. As […]

December 11, 2023 - 10 minutesmins - By Jules Adam

News and Trends 23 Feb 2023

Sherlock obtains Cas12 CRISPR patent

Sherlock Biosciences, a company engineering biology to bring next-generation lab-quality diagnostic testing to the point of need, has announced that the U.S. Patent and Trademark Office (USPTO) has granted a patent for the diagnostic use of the Cas12 enzyme. Sherlock Biosciences has exclusive U.S. rights to the patent from Shanghai-based Tolo Biotech, plus additional intellectual […]

February 23, 2023 - 3 minutesmins - By Jim Cornall

Expert Advice 16 Feb 2023

Five things you need to know about using CRISPR/Cas9 commercially

By Michael Arciero, vice president of intellectual property and corporate development, ERS Genomics CRISPR/Cas9 gene editing technology is a patented invention, so any commercial use requires a license. Despite the confusion caused by several high-profile patent interference cases, the patent landscape for CRISPR/Cas9 is clearer than you may think. Here are the 5 key facts […]

February 16, 2023 - 6 minutesmins - By External Contributor

News and Trends 9 Jan 2023

Cartherics granted first patent in China

Cartherics Pty Ltd, a biotechnology company developing immune cell therapies for the treatment of cancer, has been granted a Chinese patent, “Genetically modified cells and uses thereof.” The patent provides a proprietary position for multiple development candidates in Cartherics’ pipeline. Specifically, it covers Cartherics’ chimeric antigen receptor (CAR) targeting tumor-associated glycoprotein-72 (TAG-72), along with T […]

January 9, 2023 - 2 minutesmins - By Jim Cornall

News and Trends 1 Jan 2023

Watch: Addressing IP with Starting Bloch

Starting Bloch is a French-headquartered company helping companies navigate the world of IP and patents. The company’s Patman platform was developed to assist companies with patents, licenses and trademarks. The company also assists companies addressing fundraising, as well as helping with management and tech transfer. Patman gives companies a calendar of events to address issues […]

January 1, 2023 - 1 minutemin - By Jim Cornall

News and Trends 22 Nov 2022

Achilles Therapeutics receives US patent for immunotherapies

A U.S. patent has been granted to Achilles Therapeutics plc for the treatment of patients with an immunotherapy, including vaccine, antibody and autologous T cell therapy approaches, targeting clonal neoantigens identified using the Achilles Clonality Engine (ACE). ACE is a proprietary method for determining clonality of patient-specific mutations that drives the PELEUS bioinformatics platform. Clonal […]

November 22, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 4 Oct 2022

Patents granted for Poolbeg Pharma influenza and respiratory virus infections treatments

Poolbeg Pharma has been granted patents by the US Patent and Trademark Office (USPTO) for POLB 001, a small molecule immunomodulator for the treatment of severe influenza and POLB 002, a first-in-class, intranasally administered RNA-based immunotherapy for respiratory virus infections. POLB 001 The USPTO granted a patent for the majority of Poolbeg’s claims around the […]

October 4, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 20 Sep 2022

Regen BioPharma files patent on new RNA/DNA-based approach to cancer immunotherapy

Regen BioPharma, Inc. has filed a provisional patent application with the USPTO entitled “Dual Checkpoint Inhibitor Aptamer Based Therapeutics.” The application covers novel compositions of matter capable of acting as conventional checkpoint inhibitor drugs while simultaneously silencing genes that regulate T cells and cancer cells such as NR2F6 and Survivin. The company says this platform […]

September 20, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 6 Sep 2022

Salipro Biotech obtains patents for direct extraction of membrane proteins and library generation

Salipro Biotech AB, a Swedish biotech company with a platform for the stabilization of membrane proteins for drug development, has had patents issued by both the U.S. Patent and Trademark Office and the China National Intellectual Property Administration. The patent is entitled “Saposin lipoprotein particles and libraries from crude membranes.” The patents cover the company’s […]

September 6, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 29 Aug 2022

PharmAla Biotech files patent applications for MDMA analogs

Canadian company PharmAla Biotech has filed a key patent cooperation treaty (PCT) application, containing six novel chemical entities (NCEs). The application claims priority to, and benefit of a United States provisional patent application filed August 20, 2021. The PCT application disclosed novel compositions of MDMA and analogs that may be used to alleviate the known […]

August 29, 2022 - 3 minutesmins - By Jim Cornall

Covid vaccine lawsuit: Moderna vs Pfizer

News and Trends 26 Aug 2022

Moderna to sue Pfizer and German partner, BioNTech, for allegedly “copying technology”

Moderna is today (August 26) filing patent infringement lawsuits against Pfizer and its partner BioNTech in both the U.S and Germany. The mRNA-focused biotech claims the companies’ Covid-19 vaccine Comirnaty infringes patents it led between 2010 and 2016 covering Moderna’s foundational mRNA technology which the company says was critical to the development of its own […]

August 26, 2022 - 4 minutesmins - By Liza Laws

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Patents

Five biosimilar companies you should know about

European patents in biotech: how to prevent invalid patents?

Sherlock obtains Cas12 CRISPR patent

Five things you need to know about using CRISPR/Cas9 commercially

Cartherics granted first patent in China

Watch: Addressing IP with Starting Bloch

Achilles Therapeutics receives US patent for immunotherapies

Patents granted for Poolbeg Pharma influenza and respiratory virus infections treatments

Regen BioPharma files patent on new RNA/DNA-based approach to cancer immunotherapy

Salipro Biotech obtains patents for direct extraction of membrane proteins and library generation

PharmAla Biotech files patent applications for MDMA analogs

Moderna to sue Pfizer and German partner, BioNTech, for allegedly “copying technology”

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!